查詢結果分析
來源資料
相關文獻
- 頭頸部皮脂腺癌--三例報告
- The Clinical Features and Surgical Results of Malignant Eyelid Tumors
- 以p53、PCNA、C-erbB-2等單元抗體之免疫組織化學染色對眼瞼皮脂腺癌預後評估
- A Case of Muire-Torre Syndrome Presenting with Sebaceous Carcinoma Arising from Bowen's Disease of the Penis and Colonic Adenocarcinoma
- 眼瞼皮脂腺癌--30例之研究報告
- 眼瞼皮脂腺癌﹣﹣13例之臨床觀察與病理組織發現
- 眼瞼皮脂腺癌
- 楓葉鼠之皮脂腺癌
- A Rare Case of Maxillary Sinus Adenocarcinoma with Orbital Invasion Combined with Sebaceous Gland Carcinoma of Eyelid
- Multiple Extraocular Sebaceous Carcinomas of the Foot--A Case Report
頁籤選單縮合
題 名 | 頭頸部皮脂腺癌--三例報告=Sebaceous Carcinoma of the Head and Neck--Report of Three Cases |
---|---|
作 者 | 許庭碩; 林清榮; | 書刊名 | 中華民國耳鼻喉科醫學雜誌 |
卷 期 | 34:5 民88.09-10 |
頁 次 | 頁418-421 |
分類號 | 415.65 |
關鍵詞 | 瞼板腺; 皮脂腺癌; Meibomian gland; Sebaceous carcinoma; |
語 文 | 中文(Chinese) |
中文摘要 | 皮脂腺癌是頭頸部罕見的惡性腫瘤,至今未超過400例病例報告。病性通常原發 於眼瞼板腺,是一高度惡性之癌症,且有頭頸部局部轉移傾向。因其低發生率及外觀上類 似良性病變而容易延遲診斷。治療方式以廣泛手術切除為主,合併術後放射線治療。本文 報告本院耳鼻喉部自1983年至今經歷之3例皮脂腺癌合併頭頸部轉移之病例,討論其特性 、診斷及治療,並做文獻之回溯。 |
英文摘要 | Sebaceous carcinoma is an uncommon head and neck malignancy. Usually, the lesion arises in the meibomian glands of the eyelid and is a malignancy with a high potential of head and neck metastasis. Diagnosis is difficult because of its low incidence and deceptive clinical presentation. Treatment requires wide surgical excision with neck dissection and post-operative irradiation. Since 1983, we have had three patients with eyelid sebaceous carcinoma and neck masses in our department. Neck dissection was performed for the first and third patients and parotidectomy for the second. Pathological examination all revealed metastatic sebaceous carcinoma. The first two patients then received post-operative irradiation. In spite of vigorous treatment, the first patient died of multiple bone metastases two years later and the last patient showed brain metastasis three months later, only the second showed good result. It is a malignancy with poor prognosis therefore requires clinical alert for early detection and management. |
本系統中英文摘要資訊取自各篇刊載內容。